Home > Disclaimer > Late Effects


Late Effects





The Pituitary Foundation

COG Survivorship Guidelines: Hypopituitarism

COG Survivorship Guidelines: Growth Hormone deficiency

COG Survivorship Guidelines: Central Adrenal insufficiency

COG survivorship Guidelines: Hyperprolactinemia



1. Ries LAG, Melbert D, Krapcho M, et al (eds): SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. http://seer.cancer.gov/csr/1975_2004/

2. Axtell LM, Asire AJ, Myers MH (eds): Cancer Patient Survival. Report No. 5 DHEW Publ No. (NIH)77-992. Bethesda, MD, National Cancer Institute, 1976

3. Oeffinger KC, Hudson MM: Long-term complications following childhood and adolescent cancer: Foundations for providing risk-based health care for survivors. CA Cancer J Clin 54:208-236, 2004

4. Geenen MM, Cardous-Ubbink MC, Kremer LCM, et al: Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297:2705-2715, 2007

5. Diller L, Chow EJ, Gurney JG, et al: Chronic Disease in the Childhood Cancer Survivor Study Cohort: A review of Published Findings. J Clin Oncol 27:2339-2355, 2009

6. Sklar C, Whitton J, Mertens A, et al: Abnormalities of the thyroid in survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85:3227–3232, 2000

7. Faraci M, Barra S, Cohen A, et al: Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiation Oncology Biol Phys 63:1568-1575, 2005

8. Gurney JG, Kadan-Lottick NS, Packer RJ, et al: Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97:663-673, 2003

9. Punyko JA, Mertens AC, Gurney JG, et al: Long-term medical effects of childhood and adolescent rhabdomyosarcoma: A report from the childhood cancer survivor study. Pediatr Blood Cancer 44:643-653, 2005

10.  Ronckers CM, Sigurdson AJ, Stovall M, et al: Thyroid cancer in childhood cancer survivors: A detailed evaluation of radiation dose response and its modifiers. Radiat Res 166:618-628, 2006

11.  Sigurdson AJ, Ronckers CM, Mertens AC, et al: Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. Lancet 365:2014-2023, 2005

12.  Darzy KH, Shalet SM: Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 8:203-211, 2005

13.  Didcock E, Davies HA, Didi M, et al: Pubertal growth in young adult survivors of childhood leukemia. J Clin Oncol 13:2503-2507, 1995

14.  Chow EJ, Friedman DL, Yasui Y, et al: Decreased adult height in survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. J Pediatr 150:370-375, 375 e1, 2007

15.  Sklar CA: Childhood brain tumors. J Pediatr Endocrinol Metab 15:669-673, 2002 (suppl 2)

16.  Sklar CA: Growth and neuroendocrine dysfunction following therapy for childhood cancer. Pediatr Clin North Am 44:489-503, 1997

17.  Brownstein CM, Mertens AC, Mitby PA, et al: Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: A report from the childhood cancer survivor study. J Clin Endocrinol Metab 89:4422-4427, 2004






Back to top